Abstract:The combination provides better risk discrimination than use of HR and SBP alone and may provide a simple and reliable tool for risk assessment for older HF patients in clinical practice.
“…In summary, according to many authors the prognostic role of BP and HR in HF outcome cannot be overestimated. Some authors have suggested that combining HF and SBP constitutes a valuable prognostic factor in older patients with HF [39]. Nevertheless, there are still few reports concerning the prognostic value of HR and SBP combinations, products or quotients in patients with CHF.…”
Diastolic blood pressure, SBP × HR and DBP × HR products may be useful in subsequent heart failure exacerbation risk stratification. Moreover, DBP value may predict short-term mortality in patients with CHF.
“…In summary, according to many authors the prognostic role of BP and HR in HF outcome cannot be overestimated. Some authors have suggested that combining HF and SBP constitutes a valuable prognostic factor in older patients with HF [39]. Nevertheless, there are still few reports concerning the prognostic value of HR and SBP combinations, products or quotients in patients with CHF.…”
Diastolic blood pressure, SBP × HR and DBP × HR products may be useful in subsequent heart failure exacerbation risk stratification. Moreover, DBP value may predict short-term mortality in patients with CHF.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.